Clinical Services Unit
Pharmaceutical Sciences
Vancouver Acute
|
Clinical Services Unit |
CSU-Pharmaceutical Sciences Member Research, Publications, Presentations, Professional and Academic Awards (April 1, 2001 - March 31, 2002 Annual Report)Published, Refereed1. Marra F, Partovi N, Wasan KM, Kwong EH, Ensom MH, Cassidy SM, Fradet G, Levy RD. Amphotericin B disposition after aerosol inhalation in lung transplant recipients. Ann Pharmacother 2002;36:46-51. 2. St. Pierre E, Frighetto L, Marra C. Influence of standardized orders on postoperative nausea and vomiting after gynecologic surgery. Ann Pharmacother 2002;36:210-17. 3. Wong J, Shalansky K. Should all patients with type 1 diabetes melitus and microalbuminuria receive ACEI? J Inform Pharmacother 2002;8:206-9. 4. Druteika DP, Zed PJ, Ensom MHH. Role of fomepizole in the management of ethylene glycol toxicity. Pharmacother 2002;22:365-72. 5. Naumann T. Academic detailing in a hospital setting: Do face-to-face interactions influence antibiotic prescribing behaviour? J Inform Pharmacother 2002;8:200-202 6. Naumann T. One-to-one versus group sessions to improve prescribing in primary care: Is a twosome better than a herd approach? J Inform Pharmacother 2001;5:204-206. 7. Dumont RJ, Partovi N, Levy RD, Fradet G, Ensom MH. A limited sampling strategy for cyclosporine area under the curve monitoring in lung transplant recipients. J Heart Lung Transplant 2001;20:897-900. 8. Sunderji R, Gin K. Amiodarone: The pharmacological management of atrial fibrillation. J Geriatrics & Aging 2001;4:26-7,38. 9. Zed PJ, Loewen PS, Slavik RS, Marra CA. Meta-analysis of proton pump inhibitors in the treatment of bleeding peptic ulcers. Ann Pharmacother 2001;35:1528-34. 10. Sinclair S, Frighetto L, Loewen PS, Sunderji R, Marra CA, Teal P, Fagan S. Cost-utility analysis of tissue plasminogen activator for acute ischemic stroke: a Canadian healthcare perspective. Pharmacoecon 2001;19:927-36. 11. Lau TTY, Zed PJ. Does ketamine have a role in managing severe exacerbation of asthma in adults? Pharmacother 2001;21:1100-6. 12. Wilbur K, Zed P. Is propofol an optimal agent for procedural sedation and rapid sequence intubation in the emergency department? Can J Emerg Med 2001:3;302-310. 13. Shalansky K. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia: eradicate or not? Review done in J Inform Pharmaco 2001;5:207-9. 14. Wilson SJ, Wilbur K, Burton E, Anderson DR. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboemoblism. Heamostasis 2001;31:42-48. 15. Mysak T, Cadario B. Acetylsalicylic acid and angiotensin-converting enzyme inhibitors in heart failure: a serious hemodynamic interaction? A systematic critique. Can J Hosp Pharm 2001:54:83-95. 16. Slavik RS, Tisdale JE, Borzak S. Pharmacological conversion of atrial fibrillation: A systematic review of available evidence. Progress Cardiovascular Dis 2001;44(2):121-152. 17. Slavik RS. Oral amiodarone for prevention of atrial fibrillation after open heart surgery: does a fist beat scissors? Evidence Based Article Review, J Informed Pharmacother 2001;5:220-222. (http://www.informedpharmacotherapy.com/Issue5/EBP/Slavik%20R%20EBP%202001%205.htm) 18. Marra F, Robbins GM, Masri BA, Duncan C, Wasan KM, Kwong H, Jewesson PJ. Amphotericin b-loaded bone cement for the treatment of Candida albicans osteomyelitis. Can J Surg 2001:44;383-86. 1. Jewesson P. The only thing we have to fear is...fear itself. (editorial) J Inform Pharmacother 2001;7:1. 2. Conneally E., Warkentin DI, and Earl L. eds. BMT/Leukemia Pocket Manual. Third Edition, July 2001. 3. Zed P, Loewen P. Pharmacist scope of practice: A response to the 2002 ACP-ASIM Position Paper. J Informed Pharmacother 2002;8:1. 4. Loewen P, Zed P. The Journal - One year later, and the changing culture of academic publishing. J Informed Pharmacother 2002;5:1. In Press (Refereed, Non-refereed) 1. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacother 2002 (refereed, in press). 2. Yeung JK, Zed PJ. A review of etomidate for rapid sequence intubation in the emergency department. Can J Emerg Med 2002 (refereed, in press). 3. Loewen P. Advances in pharmacotherapy for nausea and vomiting: agents in development. Expert Opinion on Investigational Drugs 2002 (refereed, in press). 4. Loewen P. The COX-2 inhibitors: implications for emergency medicine practitioners. Can J Emerg Med 2002 (refereed, in press). 5. Loewen P. Nausea & Vomiting. Chapter in self medication: A Guide for Health Professionals, 3rd edition. Canadian Pharmaceutical Association 2002 (refereed, in press). 6. Esmail Z, Shalansky K, Sunderji R, Chambers K, Anton H, Fish W. Evalution of captopril for the management of hypertension in autonomic dysreflexia: a pilot study. Arch Physical Med Rehab 2001 (refereed, in press). 7. Balen R. Pharmacy Practice: Bringing information to the point of need with hand-held computers. Canadian Pharmacists Association Impact Newsletter 2002 (non-refereed, in press). Accepted (Refereed, Non-refereed) 1. Ensom MH, Partovi N, Decarie D, Dumont RJ, Fradet G, Levy RD. Pharmacokinetics and Protein Binding of Mycophenolic Acid in Stable Lung Transplant Recipients. Ther Drug Monit March 2002 (refereed, accepted). 2. Loewen P, Zed P, Jewesson P. A response to the ACP-ASIM position statement on pharmacists scope of practice. Am J Health-Syst Pharm 2002 (refereed, accepted). 3. Cook TF, Frighetto L, Marra CA, Jewesson PJ. Patterns of use and patients' attitudes towards complementary medications: a survey of adult general medicine patients at a major Canadian teaching hospital. Can J Clin Pharmacol 2001 (refereed, accepted). 4. Bosma TL, Jewesson PJJ. An Infusion Program IV Resource Nurse Consult Service: Our Experience in a Major Canadian Teaching Hospital. Journal of Intravenous Nursing 2001 (refereed, accepted). Submitted (Refereed, Non-refereed) 1. Loewen P, Sprague D. Development of a handheld computer-based tool for estimating risks and benefits of stroke prevention therapy in patients with atrial fibrillation. Am J Health-Syst Pharm (refereed, submitted March 2002). 2. Druteika D, Zed PJ. Is bupropion cardiotoxic following overdose? Ann Pharmacother (refereed, submitted February 2002). 3. Carr R, Zed PJ. Octreotide in the management of sulfonylurea-induced hypoglycemia following overdose. Ann Pharmacother (refereed, submitted February 2002). 4. Warkentin DI, Epstein JB, Campbell LM, Yip JG, Cox V, Ransier A, Barnett MJ, and Marra F. A prospective, randomized clinical trial of valacyclovir versus acyclovir in the prevention of mucocutaneous herpes simplex virus infections in neutropenic patients. Ann Pharmacother (refereed, submitted January 2002). 5. Sunderji R, Fung A, Gin K, Shalansky K, Carter C. Patient self-management of oral anticoagulation. Can Med Assoc J (refereed, submitted January 2002). 6. Sawoniak A, Shalansky K, Zed PJ, Sunderji R. Warfarin interchangeability formulary considerations: Vancouver Hospital and Health Sciences Centre experience. Can J Hosp Pharm (refereed, submitted November 2001). 7. Epstein Joel B., Tsang Andrew, Warkentin D, Ship Jonathan A. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. J Oral Oncol (refereed, submitted October 2001). 8. Marra C, Frighetto L, Goodfellow A, Wai A, Chase L, Nicol R, Leong C, Tomlinson S, Ferreira B, Jewesson P. Willingness to pay to assess patient preferences for treatment location: Outpatient vs. Hospital Antimicrobial Therapy. PharmacoEcon (refereed, submitted March, 2002). 9. Marra C, Frighetto L, Goodfellow A, Wai A, Chase L, Nicol R, Leong C, Tomlinson S, Ferreira B, Jewesson P. Health-related Quality of Life assessment in an Outpatient Parenteral Antibiotic Therapy Program. Ann Pharmacother (refereed, submitted March, 2002). In Progress 1. Gorman SK, Ronco J. Nutritionally variant streptococcal endocarditis: the aminoglycoside dosing debate. 2. Gorman SK, Zed P, Dhingra V, et al. Imipenem-cilastatin desensitization for multi-drug resistant Acinetobacter penumonia. 3. Gorman SK, Zed P, Purssell R, et al. Antidote stocking in British Columbia hospitals. 4. Clark K, Zed PJ, Abu-Laban RB, Graham L. Thrombolysis in pulseless electrical activity following massive pulmonary embolism: case report and qualitative systematic review. 5. Zed PJ, Cook T, Filiatrault L, Busser J. Outpatient treatment of deep vein thrombosis from the emergency department: clinical outcomes, patient satisfaction and economic analysis. 6. Zed PJ, Abu-Laban RB, Cadieu T, Purssell RA, Filiatrault L. Review of acute streptokinase or tissue plasminogen activator in the emergency department. 7. Zed PJ, Harder C, Harrison DW, Purssell. Retrospective evaluation of the management of skin and soft tissue infections in the emergency department. 8. Mysak T, Zed PJ. GHB toxicity: a systematic review of clinical course and treatment options. 9. Zed P, Loewen P. Systematic reviews for emergency medicine practitioners. 10. Sprague D, Loewen P, Raymond C. Selecting atypical antipsychotics for schizophrenia treatment. 11. Sprague D, Loewen P, Wilbur K. Feasibility of implementing an individualized, evidence-based stroke prevention counselling program for patients with atrial fibrillation. 12. Loewen P, Lamb S, Clugston P, Lennox P. Randomized double-blind trial of dolasetron or droperidol for postoperative nausea and vomiting prophylaxis in patients undergoing transverse rectus abdominus musculocutaneous (TRAM) surgery. 13. Leung V, Sunderji R, Zed PJ, Gin K. Switching from abciximab to eptifibatide for percutaneous coronary interventions: a local analysis (SWAP Study). 14. Slavik, RS, Jewesson PJ. Selecting Antibacterials for Outpatient Parenteral Antimicrobial Therapy (OPAT): Pharmacokinetic-Pharmacodynamic Aspects. 15. Slavik RS. The role of intravenous amiodarone for the conversion of atrial fibrillation in the emergency department. 16. Slavik RS, Zed PJ, Carr DM. Prevention and conversion of post cardiac surgery atrial fibrillation: A systematic review of antiarrhythmic interventions. 17. Slavik RS, Carr RC. The role of intravenous amiodarone as an agent for acute ventricular rate control in atrial fibrillation. 18. Partovi N. The role of cytomegalovirus (CMV) antigenemia assay for detection and prevention of CMV syndrome /disease after solid organ transplantation. 19. Lacaria K, Balen RM, Frighetto L, Lau Tim TY, Naumann, T, Jewesson Peter J. An evaluation of the Pharmaceutical Sciences Clinical Service Unit professional services in a major teaching hospital: A comparison of stakeholder perceptions. 20. Balen R, Bosma L, Davidson E, Jewesson P. Point of care use of a personal digital assistant (PDA) for patient consult management: Experience of an Intravenous Resource Nurse team in a major Canadian teaching hospital. 21. Buchowsky S, Jewesson P. An assessment of the affiliation between authors and sponsors of published clinical trials over a 20-year period: An unhealthy alliance? 1. Shalansky K. Iron sucrose injection (Venoferâ). Drug and Therapeutics Newsletter 2002;9(1):3. 2. Sunderji R. Dalteparin (Fragminâ). Drug and Therapeutics Newsletter 2002;9 (1):4,5. 3. Hussaini T, Shalansky K. Levonorgestrel (Plan Bâ). Drug and Therapeutics Newsletter 2002;8(4):2-4. 4. Wilbur K. Dipyridamole/ASA Comination (Aggrenoxâ). Drug and Therapeutics Newsletter 2002;8(3):4,5. 5. Sawoniak A. (Reviewed by Shalansky K, Sunderji R, Zed P). Warfarin Interchangeability Considerations. Drug and Therapeutics Newsletter 2002;8 (3):5,6. 6. Bandali S, Shalansky K, Low A. Salmeterol inhaler (Sereventâ). Drug and Therapeutics Newsletter 2002;8(2):3,4. 7. Leung V. (Reviewed by Potter M.). Latanoprost 0.005% eye drops (Xalatanâ). Drug and Therapeutics Newsletter 2002;8(2):4,5. 8. Zed P, Slavik R, de Lemos J, Sunderji R, Fenwick J. New Advanced Cardiac Life Support (ACLS) Guidelines: Implications for Change at VHHSC. Drug and Therapeutics Newsletter 2002;8(2):6-8. 9. Balen R, Jewesson P. Clinical Informatics Comes to VHHSC Pharmaceutical Sciences CSU. Drug and Therapeutics Newsletter 2002;8(2):8. 10. Zed PJ. The Outpatient Treatment of Skin and Soft Tissue Infections in the Emergency Department: Impact of the New VGH Program. The Research News, 2001 (June):(page 4,5). The Drug and Therapeutics Newsletter is produced by Clinical Service Unit Pharmaceutical Sciences (Vancouver Acute), Vancouver Coastal Health Authority and is distributed to approximately 296 external subscribers and 1,230 copies are distributed internally every 3 months. The newsletter is also available for review on our website at www.vhpharmsci.com. The editorial board for this publication is Karen Shalansky, Peter Loewen, Rubina Sunderji and Peter Jewesson. Research Posters/Abstracts1. Bandali S, Wilbur K, Frighetto L, Marra CA, Naumann T, Jewesson P. An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients. (Poster 26). 2002 Canadian Association for Population Therapeutics Annual Meeting, "Translating Evidence into Practice". Toronto, ON, April, 2002. 2. Partovi N, Shapiro RJ, Keown P. Therapeutic Drug Monitoring for Tacrolimus in kidney and kidney-pancreas transplant recipients. Annual Meeting of Canandian Society of Transplantation, Mont-Tremblant, PQ, February, 2002. 3. Partovi N, Greanya E, Stephens GM, Shapiro RJ, Yoshida EM, Levy RD, Sherlock CH. Role of cytomegalovirus (CMV) antigenemia assay for detection and prevention of CMV syndrome /disease after solid organ transplantation. Annual Meeting of Canandian Society of Transplantation, Mont-Tremblant, PQ, February, 2002. 4. Landsberg D, Keown P, Ross P, Partovi N, Shapiro R. Long term follow up of conversion from mycophenolate (MMF) to azathioprine (AZA) in stable renal transplant patients. Annual Meeting of Canandian Society of Transplantation, Mont-Tremblant, PQ, February, 2002. 5. Goodfellow AF, Wai AO, Marra CA, Frighetto L, Ferreira B, Leong C, Nicol R, Chase L, Tomlinson S, Jewesson PJ. Patient preferences and quality of life assessment in an outpatient parenteral antibiotic therapy (OPAT) program. Canadian Society of Hospital Pharmacists (CSHP) 33rd Professional Practice Conference, Toronto, ON, February, 2002. 6. Goodfellow A, Wai A, Marra C, Frighetto L, Ferreira B, Leong C, Nicol R, Chase L, Tomlinson S, Jewesson P. Patient preferences and quality of life assessment in an outpatient parenteral antibiotic therapy programme. 15th Annual Conference, National Association of Vascular Access Networks (NAVAN), Alexandria, VA, January, 2002. Published in Journal of Vascular Access Devices 2002;Spring:21. 7. Buchkowsky S, Jewesson P. An assessment of the affiliation between authors and sponsors of published clinical trials over a 20-year period: An unhealthy alliance? Pharmacy 405 Directed Studies Presentations, Vancouver, BC, January, 2002. 8. Partovi N, Hussaini T, Shapiro J. Scoring system for assessment of cardiac risk in kidney and kidney-pancreas transplant recipients. 5th Annual Transplantation Research Day, Vancouver, BC, December, 2001. 9. Goodfellow AF, Wai AO, Marra CA, Frighetto F, Ferreira B, Leong C, Nicol R, Chase L, Tomlinson S, Jewesson PJ. Patient preferences and quality of life assessment in an outpatient parenteral antibiotic therapy (OPAT) program. Annual Convention of the Canadian Intravenous Nurses Association, Toronto, ON, November, 2001. 10. Carr D, Shalansky K, Marra F, Mallinson A. Pharmacist utilization of the DIE test to assess aminoglycoside vestibular toxicity. Canadian Society of Hospital Pharmacists (British Columbia Branch) Residency Research Presentation Night, Vancouver, BC, May, 2001. 11. Cherry N, Shalansky K. Intradialytic parenteral nutrition: assessment of outcomes. Canadian Society of Hospital Pharmacists (British Columbia Branch) Residency Research Presentation Night, Vancouver, BC, May, 2001. 12. Goodfellow A, Wai A, Chan E, Frighetto L, Marra CA, Ferreira B, Chase L, Nicol R, Tomlinson S, Jewesson P. Cost-benefit, quality of life and willingness to pay analyses of the Home IV Antibiotic program: a Canadian perspective. The Canadian Association for Population Therapeutics Conference, Banff, AB. April, 2001. External Podium Presentations1. Balen RM. "Enhancing Your Pharmacy Practice With Your Personal Digital Assistants (PDA)". Continuing Pharmacy Education Evening, Metropolitan Hotel, Vancouver, BC, March, 2002. 2. Balen R. "Using Personal Digital Assistants (PDA's) in Pharmacy Pratice: An Overview for Beginners". Canadian Society of Hospital Pharmacists (CSHP) 33rd Professional Pratice Conference, Toronto, ON, February, 2002. (repeated at 2 sessions). 3. Balen R. "Using Personal Digital Assistants (PDA's) in Pharmacy Practice: Insights for the Advanced User". Canadian Society of Hospital Pharmacists, 33rd Professional Practice Conference, Toronto, ON, February, 2002. (repeated at 2 sessions). 4. Partovi N. "Role of cytomegalovirus (CMV) antigenemia assay for detection and prevention of CMV syndrome /disease after solid organ transplantation". Annual Meeting of Canadian Society of Transplantation, Mont Tremblant, PQ, February, 2002. 5. Frighetto L. "Patient Preferences in an Outpatient Parenteral Antibiotic Therapy (OPAT) Program". Continuing education lecture. Canadian Society of Hospital Pharmacists, 33rd Annual Professional Practice Conference, Toronto, ON, February, 2002. 6. Balen RM. "Empowering Pharmacists: Integrating Personal Digital Assistants (PDA) Into Pharmacy Practice". 11th Annual Invitational Management and Clinical Seminar for Pharmacy Managers of Community-Based Hospitals, Harrison Hot Springs, BC, February, 2002. 7. Jewesson P. "UBC Doctor of Pharmacy Program". Canadian Society of Hospital Pharmacists (British Columbia Branch) Student Lecture Series, Vancouver, BC, February, 2002. 8. Balen RM. "Introducing Personal Digital Assistants into pharmacy practice". BC Childrens & Womens Hospital Pharmacy Rounds. BC Childrens & Womens Hospital, Vancouver, BC, January, 2002. 9. Zed PJ. "An Evidence-Based Approach to the Management of Acute Coronary Syndromes". 11th Annual Invitational Management and Clinical Seminar for Pharmacy Managers of Community-Based Hospitals, Harrison Hot Springs, BC, February, 2002. 10. Loewen, P. "Literature searching skills". Presented to BC Hospital Pharmacy Residents. St. Paul's Hospital, Vancouver, BC, February, 2002. 11. Shalansky K. "Intradialytic Parenteral Nutrition". Western Dietician Conference, Richmond, BC, February, 2002. 12. Trottier L. "Non-prescription Ophthalmics". Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, February, 2002. 13. Partovi N. "Therapeutic drug monitoring of Tacrolimus in renal transplant recipients". 5th Annual Transplantation Research Day, Vancouver, BC, December, 2001. 14. Partovi N. "Role of cytomegalovirus (CMV) antigenemia assay for detection and prevention of CMV syndrome /disease after solid organ transplantation". 5th Annual Transplantation Research Day, Vancouver, BC, December, 2001. 15. Zed PJ, "Antibiotics….Handle With Care!" University of British Columbia Continuing Pharmacy Education Program, Surrey, BC, November, 2001. 16. Mysak, T. "Gabbing about GABA: A Review of Gabapentin in Neuropathic Pain". Canadian Society of Hospital Pharmacists (British Columbia Branch) 2001 Annual General Meeting, Vancouver, BC, November, 2001. 17. Slavik, R. "Shocking New Treatments for the Pharmacotherapy of Sepsis". Canadian Society of Hospital Pharmacists (British Columbia Branch) 2001 Annual General Meeting, Vancouver, BC, November, 2001. 18. Zed, P. "Evidence-based approach to the Management of Acute Coronary Syndromes". Canadian Society of Hospital Pharmacists (British Columbia Branch) 2001 Annual General Meeting (satellite symposium), Vancouver, BC, November, 2001. 19. Gorman S. "Cardiovascular Pharmacotherapy in a Nutshell". Nursing 493B, University of Victoria Nursing School, Victoria, BC, November, 2001. 20. Jewesson P. "Grantwriting skills". Research Affairs Workshops, Vancouver Hospital and Health Sciences Centre, Vancouver/Richmond Regional Continuing Education, November, 2001. 21. Sunderji R. "Therapeutic Issues in Anticoagulation". Trauma Cycle and Orthopaedic Conference, Richmond, BC, October, 2001. 22. Zed PJ, "Antibiotics….Handle With Care!" University of British Columbia Continuing Pharmacy Education Program, Kelowna, BC, October, 2001 23. Zed PJ, "Antibiotics….Handle With Care!" University of British Columbia Continuing Pharmacy Education Program, Comox, BC, October, 2001 24. Gorman S. "Acute Renal Failure: A Pharmacotherapeutic Approach". University of British Columbia, Pharmacy 501, Vancouver, BC, October, 2001. 25. de Lemos J. (and colleagues). "It's a Question of Balance". Trauma Cycle and Orthopaedic Conference, Richmond, BC, October, 2001. 26. Zed P. "Acute Pain Management of the Trauma Patient in the Emergency Department". Trauma Cycle and Orthopaedic Conference, Richmond, BC, October, 2001. 27. Loewen, P. "Current Issues in Prevention and Treatment of Migraine". Presented via teleconference to hospitals in BC on behalf of the Registered Nurses Association of British Columbia, October, 2001. 28. Partovi N. "Update on new immunosuppressive medications in solid organ transplantation". BCTS education Day, Vancouver, BC, October, 2001. 29. Partovi N. "Hyperlipidemia after renal transplantation". BCTS education Day, Vancouver, BC, October, 2001. 30. Jewesson P. "Outpatient intravenous antibiotic programs. Maintaining the flow from acute care to the community". (Opening remarks) CSU Pharmaceutical Sciences VHHSC Provincial Continuing Education Program, Vancouver, BC, September, 2001. 31. Sunderji, R. "Glycoprotein IIb/IIIa Antagonists in Percutaneous Coronary Interventions". Canadian Society of Hospital Pharmacists, BC Branch, Clinical Symposium. Vancouver, BC, September, 2001. 32. Zed PJ. "Glycoprotein IIb/IIIa Receptor Antagonists in Acute Coronary Syndromes". Canadian Society of Hospital Pharmacists (BC Branch) Clinical Symposium, Vancouver, BC, September, 2001. 33. Zed PJ. "Advances in the Management of Acute Coronary Syndromes: An Evidence-Based Approach". Canadian Society of Hospital Pharmacists (NB Branch), Moncton, NB, September, 2001. 34. Zed PJ. "Advances in the Management of Acute Coronary Syndromes: An Evidence-Based Approach". Canadian Society of Hospital Pharmacists (NB Branch), Saint John, NB, September, 2001. 35. Zed P, Harder C, Harrison, Purssell R. "Efficacy of once daily cefazolin/probenecid for the outpatient management of skin and soft tissue infections". Canadian Society of Hospital Pharmacists (BC Branch) Clinical Symposium, Vancouver, BC, September, 2001. 36. Jewesson P. "Outpatient Intravenous Antibiotic Programs: Maintaining the Flow from Acute Care to the Community (Opening Remarks)". Outpatient Intravenous Antibiotic Programs…Maintaining the Flow from Acute Care to the Community, Vancouver, BC, September, 2001. 37. Wai A, Nicol R. "The VGH Home IV Antibiotic Program: a 6-year experience and patient quality of life survey". Outpatient Intravenous Antibiotic Programs…Maintaining the Flow from Acute Care to the Community, Vancouver, BC, September, 2001. 38. Tomlinson S. "Peripherally Inserted Central Catheters (PICC): advanced care and management: selection criteria, anatomy, and troubleshooting". Outpatient Intravenous Antibiotic Programs…Maintaining the Flow from Acute Care to the Community, Vancouver, BC, September, 2001. 39. Chase L. "A PICC Program model: A team approach to designing and implementing a successful program". Outpatient Intravenous Antibiotic Programs…Maintaining the Flow from Acute Care to the Community, Vancouver, BC, September, 2001. 40. Ferreira B. "Total joint replacement Infections and the Prostalac program". Outpatient Intravenous Antibiotic Programs…Maintaining the Flow from Acute Care to the Community, Vancouver, BC, September, 2001. 41. Leong C. "Choosing the best vascular access device". Outpatient Intravenous Antibiotic Programs…Maintaining the Flow from Acute Care to the Community, Vancouver, BC, September, 2001. 42. Wilbur K. "Expanding Role of ACE Inhibitors". Canadian Society of Hospital Pharmacists (BC Branch) 2001 Clinical Symposium, Vancouver, BC, September, 2001. 43. Zed P. "Use of a cellulitis treatment protocol in the emergency department". Outpatient Intravenous Antibiotic Programs…Maintaining the Flow from Acute Care to the Community, Vancouver, BC, September, 2001. 44. Loewen P. "Literature searching skills". Presented to BC Hospital Pharmacy Residents. St. Paul's Hospital, Vancouver, BC, July, 2001. 45. Low, A. "How to deal with hard problems with soft bones in the elderly: An interactive workshop". New Ideas For Old Friends, BC's Long Term Care Pharmacy Conference Burnaby, BC, June, 2001. 46. Low, A. "Therapeutic Management of Patients with Parkinson's Disease". Canadian Society of Hospital Pharmacists (BC Branch) 4th Annual 2001 Fraser Valley Chapter Event, Langley, BC, June, 2001. 47. Shalansky K, Dossa A. "Laboratory Value Interpretation". UBC Continuing Education, Vancouver, BC, June, 2001. 48. Slavik RS. "When, and with what, should we treat acute atrial fibrillation". Cardiology Rounds, Cardiology Department, Surrey Memorial Hospital, Surrey, BC, June, 2001. 49. Balen RM. "Personal Digital Assistants in pharmacy practice". The 11th Okanagan Pharmacy Update. Lake Okanagan Resort, Kelowna, BC, May, 2001. 50. Loewen P. "Pharmacotherapy for Migraine Prevention". Presented to physicians and pharmacists at the Therapeutics Initiative's 12th Annual Drug Therapy Decision Making Course, Richmond, BC, May, 2001. 51. St. Pierre E, Frighetto L, Marra CA. "The effect and economic impact of standardized orders for PONV prophylaxis and treatment in gynecological surgery patients". 6th Annual International Society of Pharmaceutical Outcomes Research Meeting, Washington, DC, May, 2001. 52. Slavik, Richard. "When, and with what, should we treat atrial fibrillation?" 12th Annual Therapeutics Initiative Drug Therapy Decision Making Course - 2001: A Drug Odyssey, Richmond, BC, May, 2001. 53. Wai AO. "Bugs, Drugs and Prostalacs in Prosthetic Joint Infections". 24th Annual Canadian Orthopaedic Nurses Association (CONA) National Conference. The Grand Okanagan Conference Centre, Kelowna, BC, May, 2001. 54. Trottier L. "Drug Issues in Gerontology". Gerontology Department, Faculty of Arts, Simon Fraser University, Burnaby, BC, April, 2001 (repeated at 4 sessions). Internal Presentations1. Dossa A. "ABC's of Diabetes" Diabetes Clinic Patients. Vancouver Hospital & Health Sciences Centre, VGH site. (repeated at 10 sessions). 2. Warkentin, D. "Supportive Care Agents in Stem Cell Transplantation". E6 Nursing Orientation. Vancouver Hospital & Health Sciences Centre, VGH site. (repeated at 6 sessions). 3. Zed PJ. "Acute Pain Management and Conscious Sedation". Emergency Department Nursing Orientation. Vancouver Hospital & Health Sciences Centre, VGH site, March, 2002. (repeated at 3 sessions). 4. Loewen P. "Eptifibatide". Inservice education to Clinical Teaching Unit Nurses at Vancouver Hospital & Health Sciences Centre, UBCH site, March, 2002. (repeated at 9 sessions). 5. Zed PJ. "Rapid Sequence Intubation". Emergency Department Nursing Orientation. Vancouver Hospital & Health Sciences Centre, VGH site, March 2002. (repeated at 3 sessions). 6. Zed PJ. "Acute Pain Management of the Trauma". Resuscitation/Trauma Conference, Trauma Program, Department of Surgery, Vancouver Hospital & Health Sciences Centre, VGH site, March, 2002. 7. Mysak, T. "Antithrombotic Therapy and Management of Hypertension". Stroke Unit nursing orientation. Vancouver Hospital & Health Sciences Centre, VGH site, March, 2002. 8. Sunderji R. "Pharmacology of calcium channel blockers". Cardiology Pharmacology Rounds, Division of Cardiology, Vancouver Hospital & Health Sciences Centre, VGH site and St. Paul's Hospital, Vancouver, BC, March, 2002. 9. Slavik RS. "Applied pharmacokinetics and pharmacodynamics in the critically-ill" VGH/SPH ICU Fellows Didactic Session, Vancouver Hospital & Health Sciences Centre, VGH site, February, 2002. 10. Zed PJ. "Acute Pain Management of the Trauma Patient in the Emergency Department". Pharmacology Rounds, Department of Emergency Medicine, Vancouver Hospital & Health Sciences Centre, VGH site, February, 2002. 11. Sunderji R. "Pharmacology of beta-blockers: How much do you know?" Cardiology Pharmacology Rounds, Division of Cardiology, Vancouver Hospital & Health Sciences Centre, VGH site and St. Paul's Hospital. Vancouver, BC, February, 2002. 12. Mysak, T. "Gabbing about GABA: A Review of Gabapentin in Neuropathic Pain". Vancouver Hospital & Health Sciences Centre, VGH site, February, 2002. 13. Mysak, T. "Antithrombotic Therapy and Management of Hypertension". Stroke Unit nursing orientation. Vancouver Hospital & Health Sciences Centre, VGH site, February 2002. 14. Wilbur, K. "Antihypertensive Review". Emergency Department Pharmacology Rounds, Vancouver Hospital & Health Sciences Centre, VGH site, January, 2002. 15. Slavik RS. "Common drugs in neurosurgical practice: mechanisms of action and evidence for effect". Neurosurgery 512/513 Seminar, UBC Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Vancouver Hospital & Health Sciences Centre, VGH site, January, 2002. 16. Balen RM. "Practical Synergies: Information Technology and the Healthcare Professional - Examples from the Pharmaceutical Sciences". University of British Columbia Nuclear Medicine Grand Rounds. Vancouver Hospital & Health Sciences Center, VGH site, December, 2001. 17. Dossa A. "Type 2 Diabetes". Renal Clinic Nurses". Vancouver Hospital & Health Sciences Centre, VGH site, December, 2001. 18. Slavik RS. "Shocking new treatments for the pharmacotherapy of sepsis in the ED - EGDT, steroids, vasopressin, and APC" Department of Emergency Medicine Pharmacology Rounds, Vancouver Hospital & Health Sciences Centre, VGH site, December, 2001. 19. Sunderji R. "Secondary prevention of coronary artery disease: warfarin or ASA?". Cardiology Pharmacology Rounds, Division of Cardiology, Vancouver Hospital & Health Sciences Centre, VGH site and St. Paul's Hospital. Vancouver, BC, November, 2001. 20. Loewen, P. "Migraine Management in the Emergency Department". Presented to emergency physicians and pharmacists at VGH ED Pharmacology Rounds. Vancouver Hospital & Health Sciences Centre, VGH site, November, 2001. 21. Warkentin D. "Review of Lipid Formulations of Amphotericin B and Proposed Guidelines for Use at VHHSC". Bone Marrow Transplantation Seminar, Vancouver Hospital & Health Sciences Centre, VGH site, November, 2001. 22. Slavik RS. "TSCU pharmacology half day: agitation, supraventricular arrhythmias, and inotropes/vasopressors". TSCU Nursing Orientation Lecture Series, Vancouver Hospital & Health Sciences Centre, VGH site, October, 2001. 23. Mysak, T. "Antithrombotic Therapy". Neurosciences nursing orientation. Vancouver Hospital & Health Sciences Centre, VGH site, October, 2001. 24. Sunderji R. "Basic pharmacology principles of select cardiovascular drugs". Cardiology Pharmacology Rounds, Division of Cardiology, VGH site and St. Paul's Hospital, Vancouver, BC, September, 2001 25. Mysak, T. "Antithrombotic Therapy". Neurosciences nursing orientation. Vancouver Hospital & Health Sciences Centre, VGH site, September, 2001. 26. Zed PJ. "Etomidate for Rapid sequence Intubation in the VGH Emergency Department: Ready for Prime Time?" Pharmacology Rounds, Department of Emergency Medicine, Vancouver Hospital & Health Sciences Centre, VGH site, September, 2001. 27. Warkentin D. "New Drug Development - Focus on Anticancer Drugs". Research Nurses, Vancouver Hospital & Health Sciences Centre, VGH site, September, 2001. 28. Slavik RS. "Antimicrobial use in the intensive care unit: practical applications" ICU Nursing Education Series, Vancouver Hospital & Health Sciences Centre, VGH site, September, 2001. (repeated at 3 sessions). 29. Slavik RS. "Clinical application of intrope and vasopressor use in the ICU." VGH Critical Care Medical Resident Teaching Series, Vancouver Hospital & Health Sciences Centre, VGH site, August, 2001. (repeated at 2 sessions). 30. Mysak, T. "Management of Hypertension" Three part series. Stroke Rounds. Vancouver Hospital & Health Sciences Centre, VGH site, August 2001 (repeated at 2 sessions). 31. Slavik RS. "Management of HT crisis and use of inotropes and vasopressors in the neurological ICU" NICU Nursing Education Series, Vancouver Hospital & Health Sciences Centre, VGH site, July, 2001. (repeated at 2 sessions). 32. Slavik RS. "Antimicrobial therapy in the ICU: principles and practical applications" VGH Critical Care Medical Resident Teaching Series, Vancouver Hospital & Health Sciences Centre, VGH site, July, 2001. (repeated at 4 sessions). 33. Sunderji, R. Anticoagulation Self-Management: Fact or Fiction? Cardiology Grand Rounds, Vancouver Hospital & Health Sciences Centre, VGH site, June, 2001. 34. Sunderji R. "Amiodarone: A review of pharmacology and evidence for pharmacological conversion of atrial fibrillation". Cardiology Pharmacology Rounds, Division of Cardiology, VGH site and St. Paul's Hospital, Vancouver, BC, May, 2001. 35. Slavik RS. "Traumatic brain injury in the ED: pharmacological and supportive treatment". Emergency Medicine Research Rounds, Department of Emergency Medicine, Vancouver Hospital and Health Sciences Centre, VGH site, May, 2001. 36. Slavik RS. "Pharmacological prophylaxis of radial artery vasospasm after coronary artery bypass graft surgery". CSICU Pharmacology Rounds, Vancouver Hospital & Health Sciences Centre, VGH site, May, 2001. 37. Shalansky K. "Drugs and Renal Failure". Renal technicians, Vancouver Hospital & Health Sciences Centre, VGH site, May, 2001. 38. Slavik RS. "Stress ulcer and venous thromboembolism prophylaxis in trauma patients." TSCU Resident Orientation Day, Vancouver Hospital & Health Sciences Centre, VGH site, April, 2001. (repeated monthly x9). 39. Dossa A. "High Risk Patient Intervention Program". Western Canadian Hospital Pharmacists. AstraZeneca Video Conference. Vancouver Hospital & Health Sciences Centre, VGH site, March, 2001. Professional Awards1. DeLemos, J. 2001 VHHSC Professional Affairs Bursary Award which will be for continuing education purposes, September 2001. 2. Alladina, S is the recipient of the 2001 VHHSC Professional Affairs Bursary Award which will be for continuing education purposes, September 2001. 3. Cox, V is the recipient of the 2001 VHHSC Professional Affairs Bursary Award which will be for continuing education purposes, September 2001. Research Awards1. Goodfellow Alan F., Wai Amy O., Marra Carlo A., Frighetto Luciana, Ferreira Barbara, Leong Carole, Nicol Ruth, Chase Lynn, Tomlinson Sally, Jewesson Peter J. Patient preferences and quality of life assessment in an outpatient parenteral antibiotic therapy (OPAT) program. Canadian Society of Hospital Pharmacists/Novartis Pharmacoeconomic National Research Award. 2. Carr Denise, Shalansky Karen, Marra Fawziah, Mallinson Art. Pharmacist Utilization of the DIE test to assess aminoglycoside vestibulotoxicity. Canadian Society of Hospital Pharmacists/GlaxoSmithKline (Pharmaceutical Care) National Research Award. 3. Goodfellow A, Wai A, Marra C, Frighetto L, Ferreira B, Leong C, Nicol R, Chase L, Tomlinson S, Jewesson P. Patient preferences and quality of life assessment in an outpatient parenteral antibiotic therapy programme. 15th Annual Conference, National Association of Vascular Access Networks (NAVAN), Alexandria, VA, USA, January, 2002. (First Place, Research category of the NAVAN poster competition). 4. Zed P, Harder C, Harrison David W., Purssell Roy A. Efficacy of once daily cefazolin/probenecid for the outpatient management of skin and soft tissue infections. Canadian Society of Hospital Pharmacists (BC Branch) Clinical Symposium. Pfizer Pharmacy Practice Award for best research poster. Vancouver, BC, September, 2001. Academic Awards1. Greanya E. Canadian Society of Hospital Pharmacists (BC Branch) (co-sponsored by DuPont Pharmaceuticals) Interhospital Competition for Highest Ranked Resident, 2001. 2. Cherry N, Shalansky K. Intradialytic Parenteral Nutrition: Assessment of Outcomes. Canadian Society of Hospital Pharmacists (BC Branch) Award (co-sponsored by Pharmacia Pharmaceuticals) for highest ranked B.C. residency project. 3. Leung V. BC Pharmacy Association 2001 New Horizons Award for Community Practice. 4. Zed P. Past President Award, Canadian Society of Hospital Pharmacists (BC Branch), 2001. |